Lynn native makes history as first non-binary person to win a Tony award for acting
Published Tue, 04 Mar 2025 17:13:35 GMT
Finals MVP Nikola Jokic carries Nuggets to first championship in franchise history after eliminating Heat
Published Tue, 04 Mar 2025 17:13:35 GMT
California Gov. Newsom spars with Fox News host Hannity over Biden, immigration and the economy
Published Tue, 04 Mar 2025 17:13:35 GMT
Denver Nuggets, Canadian Jamal Murray win 1st-ever NBA title
Published Tue, 04 Mar 2025 17:13:35 GMT
Teen, paralyzed in water accident, warns others of the dangers of diving
Published Tue, 04 Mar 2025 17:13:35 GMT
Hardly drought busters, but showery spells to increase Tuesday with slow moving low pressure; Canadian fires still burning and smoke may stage a Chicago area comeback in coming days
Published Tue, 04 Mar 2025 17:13:35 GMT
Denver Nuggets win first NBA title, beat Miami Heat in five games
Published Tue, 04 Mar 2025 17:13:35 GMT
Heat and humidity reach dangerous levels this week
Published Tue, 04 Mar 2025 17:13:35 GMT
Session adjourns, Assembly plans to reconvene
Published Tue, 04 Mar 2025 17:13:35 GMT
Police tie 12-year-old girl to overnight crime spree
Published Tue, 04 Mar 2025 17:13:35 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says